AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Functional Brands Inc. Announces P2i by Kirkman as First Prenatal Supplement to Align with FIGO Transparency Standards and Comply with California's SB 646 Law
ByAinvest
Tuesday, Dec 2, 2025 8:10 am ET1min read
Functional Brands Inc. announced that P2i by Kirkman Prenatal Multivitamin & Multimineral is the first prenatal supplement to align with the International Federation of Gynecology and Obstetrics' transparency standards and comply with California's SB 646 QR-code disclosure law. P2i is tested for 120 toxicants and 24 heavy metals, and its test results are publicly accessible through a QR code on the packaging. The supplement is designed to meet the urgent need for prenatal nutrition that is both scientifically formulated and transparently tested.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet